Amikacin
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281627This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84319SGC3C. European Medicines Agency schedules Amikacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05431MIG. Amikacin generally arises in the molecular formula C22H43N5O13. The term AMIKACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, no. 10 1974, list 14.) AMIKACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amikacin under HS 29419000 and SITC 54139. As of Q4 2014, AMIKACIN remains the US FDA Preferred Term for this commodity. Amikacin bears US NLM identifiers UMLS ID C0002499 and NCI Concept Code C61615. SMILES: O(C1C(NC(=O)C(O)CCN)CC(N)C(OC2OC(C(O)C(O)C2O)CN)C1O)C1OC(C(O)C(N)C1O)CO.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.